What is the Impact Factor of Sarcoma?

The journal Sarcoma is indexed in Web of Science (SCIE, quartile Q1) with official metrics continually updated on ImpaQ.

Is Sarcoma indexed in Web of Science or Scopus?

Yes, Sarcoma is indexed in Web of Science (SCIE, Q1 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.560 (Q2) and an H-index of 57.

Who publishes Sarcoma and what is the Article Processing Charge (APC)?

Sarcoma is published by Hindawi. The estimated Article Processing Charge (APC) is approximately $3,036 USD, subject to institutional waivers and corresponding author affiliations.

WoS SCIE Q1Scopus Q2SCImago #10,597Diamond OA

Sarcoma

Identifier (ISSN):1357-714X(Print)/1369-1643(Online)

•

Publisher:Hindawi

Clarivate JCR Index Advisory: Not Indexed in Latest JCR

Official Website Submission Portal Compare

Clarivate Impact Factor (IF 2024)

N/A

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

Impact Factor Trend

Clarivate IF trend for Sarcoma

WoS Q1

Annual Impact Factor Metric

Current (2025):0

Scopus SJR & RankScopus Q2

0.56

#10,597

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

57 papers with at least that number of citations each

WoS: SCIE / JCRQ1

Self-Citation RateN/A

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessDiamond OA

9articles/year

0% Gold OA•0% Original Research

Aims & Scope

Sarcoma is dedicated to publishing papers covering all aspects of connective tissue oncology research. It brings together work from scientists and clinicians carrying out a broad range of research in this field, including the basic sciences, molecular biology and pathology and the clinical sciences of epidemiology, surgery, radiotherapy and chemotherapy. High-quality papers concerning the entire range of bone and soft tissue sarcomas in both adults and children, including Kaposi"s sarcoma, are published as well as preclinical and animal studies. This journal provides a central forum for the description of advances in diagnosis, assessment and treatment of this rarely seen, but often mismanaged, group of patients.

Topics Covered (Recognized by AI)

Medicine99.7%Pathology86%Biology83.5%Internal medicine81.1%Surgery76.1%Genetics66.6%Radiology62.5%Sarcoma49.7%Cancer33.2%Chemistry32%Chemotherapy29.6%Cancer research29.4%Soft tissue28.8%Oncology24.1%Biochemistry23.8%Mathematics22.6%

Primary Research Areas

Medicine Radiology Nuclear Medicine and Imaging

Official Website NLM PubMed Catalog SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR

No WoS category details available for this journal.

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

13 year

2025Latest

IF0

Articles / Year—

Total Citations—

2024

IF—

Articles / Year9

Total Citations34

2023

IF—

Articles / Year4

Total Citations53

2022

IF—

Articles / Year18

Total Citations89

2021

IF—

Articles / Year25

Total Citations261

Year	Impact Factor	Articles / Year	Total Citations
2025	0	—	—
2024	—	9	34
2023	—	4	53
2022	—	18	89
2021	—	25	261
2020	—	56	613
2019	—	30	634
2018	—	33	795
2017	—	48	610
2016	—	27	542
2015	—	35	1,212
2014	—	25	1,019
2013	—	42	1,524

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #10,597Scopus Q2SCImago Profile

Scopus Coverage:1997-2024

•

Scopus Broad Areas:Medicine

Scopus Citation Rank (SJR)Q2

0.56

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2

Citations / Doc (2 years)

2.90

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,036 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations53

3-Year Documents26

Citable Documents26

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate0.0%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Radiology, Nuclear Medicine and ImagingQ2

OncologyQ3

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: N/A

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

Updating

Minor Category (Specific Field):

Updating

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Sarcoma (ISSN: 1357-714X) is a peer-reviewed international scholarly journal in the field of Medicine, published by Hindawi in United Kingdom. The periodical holds tracked under Web of Science (SCIE) in quartile Q1, a Scopus SJR indicator of 0.560 (Q2), an H-index of 57.

The journal enforces rigorous peer evaluation with an annual output of approximately 9 scientific articles. In terms of accessibility and author fees, it operates under the Diamond OA model with an estimated APC of $3,036 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.